<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0002048323</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001612042</issuerCik>
      <issuerName>Ascendis Pharma A/S</issuerName>
      <secFileNumber>001-36815</secFileNumber>
      <issuerAddress>
        <com:street1>TUBORG BOULEVARD 12</com:street1>
        <com:city>HELLERUP</com:city>
        <com:stateOrCountry>G7</com:stateOrCountry>
        <com:zipCode>DK-2900</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>45 70 22 22 44</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Shu Aimee</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Officer</relationshipToIssuer>
        <relationshipToIssuer>EXECUTIVE VICE PRESIDENT CHIEF MEDICAL OFFICER</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>ORDINARY SHARES</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>CITIGROUP GLOBAL MARKETS</name>
        <address>
          <com:street1>390 GREENWICH STREET</com:street1>
          <com:city>NEW YORK</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10013</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>4204</noOfUnitsSold>
      <aggregateMarketValue>700412.45</aggregateMarketValue>
      <noOfUnitsOutstanding>57707439</noOfUnitsOutstanding>
      <approxSaleDate>05/06/2025</approxSaleDate>
      <securitiesExchangeName>NASDAQ</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>ORDINARY SHARES</securitiesClassTitle>
      <acquiredDate>05/06/2025</acquiredDate>
      <natureOfAcquisitionTransaction>ASCENDIS SHARE PLAN</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>ASCENDIS PHARMA A/S</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>4204</amountOfSecuritiesAcquired>
      <paymentDate>05/06/2025</paymentDate>
      <natureOfPayment>COMPENSATION</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <remarks>UNDER SECURITIES TO BE SOLD DATE ACQUIRED AND DATE PAYMENT VARIOUS YEARS. SHARES WERE SOLD FROM THE ASCENDIS SHARE PLAN
AGGREGATE FMV USED INDICATIVE MARKET PRICE 166.606196</remarks>
    <noticeSignature>
      <noticeDate>05/07/2025</noticeDate>
      <signature>CONFORMED SIGNATURE ON FILE</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
